Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.5M | Sell |
207,980
-161,508
| -44% | -$9.91M | ﹤0.01% | 1656 |
|
|
2026
Q1 | $24.1M | Buy |
369,488
+10,784
| +3% | +$789K | 0.01% | 1022 |
|
|
2025
Q4 | $28.9M | Buy |
358,704
+4,800
| +1% | +$386K | 0.01% | 929 |
|
|
2025
Q3 | $29M | Sell |
353,904
-13,782
| -4% | -$1.19M | 0.01% | 907 |
|
|
2025
Q2 | $33.5M | Sell |
367,686
-35,822
| -9% | -$3.2M | 0.01% | 790 |
|
|
2025
Q1 | $36.9M | Sell |
403,508
-30,221
| -7% | -$2.64M | 0.01% | 761 |
|
|
2024
Q4 | $36.9M | Sell |
433,729
-8,106
| -2% | -$711K | 0.01% | 802 |
|
|
2024
Q3 | $38.7M | Sell |
441,835
-6,102
| -1% | -$514K | 0.01% | 790 |
|
|
2024
Q2 | $35.4M | Sell |
447,937
-24,373
| -5% | -$2M | 0.01% | 802 |
|
|
2024
Q1 | $42.7M | Sell |
472,310
-7,956
| -2% | -$725K | 0.01% | 709 |
|
|
2023
Q4 | $42.2M | Sell |
480,266
-1,535
| -0.3% | -$128K | 0.01% | 685 |
|
|
2023
Q3 | $40.7M | Buy |
481,801
+21,302
| +5% | +$1.92M | 0.01% | 641 |
|
|
2023
Q2 | $45.5M | Sell |
460,499
-5,358
| -1% | -$504K | 0.02% | 607 |
|
|
2023
Q1 | $44.7M | Sell |
465,857
-7,405
| -2% | -$685K | 0.02% | 597 |
|
|
2022
Q4 | $43M | Sell |
473,262
-5,669
| -1% | -$482K | 0.02% | 597 |
|
|
2022
Q3 | $38.1M | Buy |
478,931
+4,245
| +0.9% | +$360K | 0.02% | 645 |
|
|
2022
Q2 | $39.5M | Buy |
474,686
+6,164
| +1% | +$508K | 0.02% | 645 |
|
|
2022
Q1 | $38.3M | Buy |
468,522
+4,101
| +0.9% | +$321K | 0.01% | 770 |
|
|
2021
Q4 | $34.8M | Sell |
464,421
-7,674
| -2% | -$576K | 0.01% | 898 |
|
|
2021
Q3 | $35.7M | Sell |
472,095
-108,145
| -19% | -$8.37M | 0.01% | 874 |
|
|
2021
Q2 | $44.9M | Sell |
580,240
-127,455
| -18% | -$9.84M | 0.01% | 806 |
|
|
2021
Q1 | $49.6M | Sell |
707,695
-163,215
| -19% | -$12.3M | 0.02% | 731 |
|
|
2020
Q4 | $61.8M | Buy |
870,910
+378,808
| +77% | +$23.8M | 0.02% | 594 |
|
|
2020
Q3 | $28.3M | Sell |
492,102
-46,725
| -9% | -$2.79M | 0.01% | 860 |
|
|
2020
Q2 | $32.8M | Sell |
538,827
-154,317
| -22% | -$9.53M | 0.01% | 746 |
|
|
2020
Q1 | $38.1M | Sell |
693,144
-8,372
| -1% | -$561K | 0.02% | 587 |
|
|
2019
Q4 | $50.6M | Sell |
701,516
-67,215
| -9% | -$4.58M | 0.02% | 664 |
|
|
2019
Q3 | $50.8M | Buy |
768,731
+86,464
| +13% | +$5.56M | 0.02% | 645 |
|
|
2019
Q2 | $42.4M | Buy |
+682,267
| New | +$39.4M | 0.02% | 766 |
|
|
2016
Q1 | – | Sell |
-40,622
| Closed | -$2.22M | – | 1435 |
|
|
2015
Q4 | $2.22M | Buy |
40,622
+15,438
| +61% | +$885K | 0.01% | 731 |
|
|
2015
Q3 | $1.43M | Buy |
+25,184
| New | +$1.44M | 0.01% | 930 |
|
|
2015
Q1 | – | Sell |
-6,573
| Closed | -$307K | – | 1605 |
|
|
2014
Q4 | $307K | Buy |
6,573
+611
| +10% | +$28.6K | ﹤0.01% | 1468 |
|
|
2014
Q3 | $274K | Sell |
5,962
-22,736
| -79% | -$1.06M | ﹤0.01% | 1461 |
|
|
2014
Q2 | $1.33M | Sell |
28,698
-15,176
| -35% | -$715K | 0.01% | 1012 |
|
|
2014
Q1 | $2.04M | Buy |
43,874
+4,477
| +11% | +$196K | 0.01% | 796 |
|
|
2013
Q4 | $1.63M | Buy |
39,397
+1,590
| +4% | +$62.6K | 0.01% | 862 |
|
|
2013
Q3 | $1.39M | Buy |
37,807
+9,473
| +33% | +$358K | 0.01% | 958 |
|
|
2013
Q2 | $1.05M | Buy |
+28,334
| New | +$1.01M | 0.01% | 1007 |
|
Other funds holding DOX
BGC
BIP
Nuveen's DOX Position: Q2 2026 in Review
Nuveen reduced its Amdocs (DOX) stake by 44% in Q2 2026, selling an estimated $9.91M and leaving 207,980 shares worth $10.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1656.
Nuveen first reported a position in DOX in Q2 2013 and has held it in 38 quarters since. The position peaked at $61.8M in Q4 2020. 447 funds tracked by Wall St. Rank hold DOX as of Q2 2026.
- Nuveen held 207,980 shares of Amdocs worth $10.5M as of Q2 2026.
- Nuveen sold 161,508 Amdocs shares in Q2 2026, an estimated $9.91M.
- Amdocs made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #1656 holding.
- Nuveen first reported a position in Amdocs in Q2 2013 and has held it in 38 quarters since.
- Nuveen's Amdocs position peaked at $61.8M in Q4 2020.
- 447 funds tracked by Wall St. Rank held Amdocs as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.